<i>In vitro</i> investigating of anticancer activity of new 7-MEOTA-tacrine heterodimers

Jana Janočková(University of Pavol Jozef Šafárik), Ondřej Soukup(University Hospital Hradec Králové), Jana Vargová(University of Pavol Jozef Šafárik), Ján Rosocha(University of Pavol Jozef Šafárik), Jana Kašpárková(Czech Academy of Sciences, Institute of Biophysics), Katerina Babkova(Military University), Peter Fedoročko(University of Pavol Jozef Šafárik), Ján Kovaĺ(University of Pavol Jozef Šafárik), Slávka Hamuľaková(University of Pavol Jozef Šafárik), Kamil Kuča(University Hospital Hradec Králové), Viktor Brabec(Czech Academy of Sciences), Jan Korábečný(University of Defence), Dana Kučerová(University of Pavol Jozef Šafárik), Jana Plšíková(University of Pavol Jozef Šafárik), Rastislav Jendželovský(University of Pavol Jozef Šafárik), Eva Konkoľová(Institute of Chemistry of the Slovak Academy of Sciences)
Journal of Enzyme Inhibition and Medicinal Chemistry
January 1, 2019
Cited by 22


Related Papers